Iovance Biotherapeutics (IOVA) Other financing activities (2016 - 2026)
Iovance Biotherapeutics' Other financing activities was $1.17 million in Q2 2026, up 131.3% from $504,000 a year earlier but down 72.1% from the prior quarter.
Iovance Biotherapeutics (IOVA) Other financing activities (2016 - 2026) Analysis & Trends
On a trailing twelve-month basis, Iovance Biotherapeutics' Other financing activities was $6.26 million through Jun 30, 2026, down 53.0% year-over-year; for FY2025, it came in at $7.06 million, down 45.1% from FY2024.
- Other financing activities shows a five-year compound annual growth rate of 90.1% (FY2020 to FY2025).
- In earlier years, Other financing activities was $12.86 million in FY2024 (+360.0%), $2.8 million in FY2023 (+5.5%) and $2.65 million in FY2022.
- Quarterly Other financing activities has moved between $186,000 (Q4 2023) and $6.28 million (Q3 2024) over five years.
- Compared with a year earlier, Other financing activities was higher in three of the last seven quarters, with growth averaging 43.9%.
- The best year-over-year quarter for Other financing activities over five years was Q4 2024 (growth of 373.1%); the worst was Q3 2025 (a decline of 92.6%).
- Per Business Quant data, IOVA's Other financing activities in the three quarters before Q2 2026 was $4.18 million (Q1 2026), $445,000 (Q4 2025) and $466,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Iovance Biotherapeutics | 4.98 Bn | 3.77 Bn | 55.72 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.17 Mn |
| Mar 31, 2026 | 4.18 Mn |
| Dec 31, 2025 | 445,000.00 |
| Sep 30, 2025 | 466,000.00 |
| Jun 30, 2025 | 504,000.00 |
| Mar 31, 2025 | 5.64 Mn |
| Dec 31, 2024 | 880,000.00 |
| Sep 30, 2024 | 6.28 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 4.70 Mn |
| Dec 31, 2023 | 186,000.00 |
| Sep 30, 2023 | 379,000.00 |
| Jun 30, 2023 | 301,000.00 |
| Mar 31, 2023 | 1.93 Mn |
| Jun 30, 2022 | 2.65 Mn |
| Dec 31, 2020 | 1,000.00 |
| Jun 30, 2020 | 165,000.00 |
| Mar 31, 2020 | 118,000.00 |
| Dec 31, 2019 | 119,000.00 |
| Sep 30, 2019 | 98,000.00 |
Iovance Biotherapeutics Other financing activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=IOVA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();